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Among RNA viruses, the order Nidovirales stands out for including viruses with
the largest RNA genomes currently known. Nidoviruses employ a complex RNA-
synthesizing machinery comprising a variety of non-structural proteins (nsps). One of
the postulated drivers of the expansion of nidovirus genomes is the presence of a
proofreading 3′-to-5′ exoribonuclease (ExoN) belonging to the DEDDh family. ExoN may
enhance the fidelity of RNA synthesis by correcting nucleotide incorporation errors made
by the RNA-dependent RNA polymerase. Here, we review our current understanding
of ExoN evolution, structure, and function. Most experimental data are derived from
studies of the ExoN domain of coronaviruses (CoVs), which were triggered by the
bioinformatics-based identification of ExoN in the genome of severe acute respiratory
syndrome coronavirus (SARS-CoV) and its relatives in 2003. Although convincing data
supporting the proofreading hypothesis have been obtained, from biochemical assays
and studies with CoV mutants lacking ExoN functionality, the features of ExoN from most
other nidovirus families remain to be characterized. Remarkably, viable ExoN knockout
mutants were obtained only for two CoVs, mouse hepatitis virus (MHV) and SARS-
CoV, whose RNA synthesis and replication kinetics were mildly affected by the lack
of ExoN function. In several other CoV species, ExoN inactivation was not tolerated,
and knockout mutants could not be rescued when launched using a reverse genetics
system. This suggests that ExoN is also critical for primary viral RNA synthesis, a
property that poorly matches the profile of an enzyme that would merely boost long-
term replication fidelity. In CoVs, ExoN resides in a bifunctional replicase subunit (nsp14)
whose C-terminal part has (N7-guanine)-methyltransferase activity. The crystal structure
of SARS-CoV nsp14 has shed light on the interplay between these two domains, and
on nsp14’s interactions with nsp10, a co-factor that strongly enhances ExoN activity
in vitro assays. Further elucidation of the structure-function relationships of ExoN and
its interactions with other (viral and/or host) members of the CoV replication machinery
will be key to understanding the enzyme’s role in viral RNA synthesis and pathogenesis,
and may contribute to the design of new approaches to combat emerging nidoviruses.
Keywords: nidovirus, non-structural protein 14, exoribonuclease, N7-methyltransferase, proofreading,
coronavirus
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INTRODUCTION
RNA viruses typically exhibit a high mutation frequency. This
intrinsic biological property facilitates rapid adaptation of the
virus to changing circumstances, a major contributor to the
frequent outbreaks of mutated or newly emerging RNA viruses in
humans, livestock, and other host organisms. The poor fidelity of
RNA virus genome replication is attributed primarily to the fact
that errors made by the viral RNA-dependent RNA polymerase
(RdRp) go uncorrected. This lack of proofreading results in
“quasispecies” populations of closely related viral genomes that
are subject to continuous natural selection. As the accumulation
of an excessive number of deleterious mutations can result in
“error catastrophe,” the low fidelity of their replication is thought
to have restricted genome size, which for most RNA virus families
is (well) below 15 kilobases (Steinhauer et al., 1992; Drake and
Holland, 1999; Eigen, 2002). This evolutionary trade-off between
RNA virus genome size, replication fidelity, and adaptive capacity
has been explored both from a fundamental perspective and in
the context of antiviral drug development (Crotty et al., 2001).
The balance between quasispecies diversity and viral fitness
appears to be easily disturbed, suggesting that RNA viruses in
general may operate close to their error threshold (Pfeiffer and
Kirkegaard, 2005; Vignuzzi et al., 2006; Manrubia et al., 2010).
Clearly, in the absence of countermeasures to reduce the overall
error rate, similar issues would be expected upon the significant
expansion of RNA virus genome size.
The largest RNA genomes currently known are all found
in the order Nidovirales, an order of positive-stranded RNA
(+ RNA) viruses that includes the coronavirus (CoV) family
as its best-studied taxon. Recent nidovirus additions (Bukhari
et al., 2018; Saberi et al., 2018) have increased the known
upper limit of RNA genome size from just above 30 kb (for
most CoVs) to more than 41 kb in a nidovirus identified in
a planarian host, which was named planarian secretory cell
nidovirus (PSCNV) (Saberi et al., 2018). About 15 years ago,
during the in-depth bioinformatics analysis of the genome and
proteome of the severe acute respiratory syndrome coronavirus
(SARS-CoV), Alexander Gorbalenya and co-workers identified
a 3′-5′ exoribonuclease (ExoN) signature sequence in a domain
embedded in the replicase polyprotein of CoVs and other
nidoviruses with a similarly large RNA genome, and speculated
about its role as a proofreading enzyme in the evolution of
such large nidovirus genomes (Snijder et al., 2003). Shortly after
this ground-breaking discovery, ExoN activity was demonstrated
biochemically for SARS-CoV (Minskaia et al., 2006) and –
following its inactivation by reverse genetics – was indeed
implicated in enhancing CoV replication fidelity (Eckerle
et al., 2007). Subsequently, the enzyme was the subject of
further virological, biochemical, structural, and genetics studies.
Evidence strongly supporting the “proofreading exoribonuclease”
hypothesis has now accumulated, in particular for SARS-CoV
and murine hepatitis CoV (MHV) (Bouvet et al., 2012; Smith
and Denison, 2012), and will be summarized below. At the same
time, quite different observations were made for multiple other
CoVs, highlighting the need for a more extensive experimental
characterization of the importance and function of the unique
ExoN domain, both within the CoV family and in other
nidovirus subgroups.
ExoN acquisition by a nidoviral ancestor and the subsequent
development of a beneficial interplay with the viral RNA RdRp
(Subissi et al., 2014a; Ferron et al., 2018) are thought to have been
key steps in relieving the constraints on genome size expansion
in this virus lineage (Nga et al., 2011). Strikingly, the replication
of arteriviruses, the nidovirus family with the smallest genome
(12–16 kb), does not depend on the presence of an ExoN domain
in the viral replicase (Snijder et al., 2003), suggesting they either
diverged from other nidoviruses before ExoN acquisition or lost
ExoN at a later stage of their evolutionary trajectory.
THE AMAZING DIVERSITY OF
NIDOVIRUSES
The orderNidovirales currently comprises 88 formally recognized
virus species of + RNA viruses, which are classified in nine
virus families across seven different suborders (Siddell et al.,
2019)1. These agents can infect a striking variety of vertebrate
and invertebrate hosts, including mammals, birds, amphibians,
fish, reptiles, arthropods, molluscs, and helminths. Additional
nidovirus genome sequences continue to be described, due to
the extensive metagenomics-based virus discovery efforts of the
past decade (Saberi et al., 2018). Their adequate classification
will undoubtedly require the creation of additional nidovirus
taxa. Unfortunately, the biological and (possible) pathogenic
features of most novel nidoviruses remain uncharacterized thus
far (Shi et al., 2016, 2018a,b).
The groundwork for the nidovirus order was laid in the late
1980s when the first full-length genome sequences of corona-
, arteri-, and toroviruses revealed striking similarities at the
level of genome organization and expression. Moreover, the
conservation of an array of replicase domains in these distantly
related genomes pointed toward a common ancestry of the core
of their replicative machinery, including the RNA-dependent
RNA polymerase (RdRp) and helicase enzymes (den Boon et al.,
1991). These findings were surprising at the time, in particular
given the very different appearance and features of corona-
, arteri-, and torovirus particles, and the large differences in
genome size, which ranged from less than 13 kb for the arterivirus
equine arteritis virus (EAV) to more than 31 kb for some CoVs,
like MHV. The latter property placed the CoVs far apart from
all other viral families characterized in the final decades of the
20th century (Gorbalenya et al., 2006). This unique position
also raised questions about the processivity and fidelity of the
CoV RNA-synthesizing machinery, particularly in the light of the
development of the emerging RNA virus quasispecies concept
and the notion that RNA virus genome sizes are constrained by
the high mutation rate of their RdRp (see above).
The advent of metagenomics has taken our understanding
of nidovirus host and genome diversity to the next level (Shi
et al., 2016, 2018a,b; Zumla et al., 2016), even though most
of these new sequences remain to be analyzed in detail and
1ICTV website: https://talk.ictvonline.org/taxonomy/
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many branches of the revised nidovirus order remain sparsely
populated. In terms of RNA genome size, the known upper limit
increased to more than 41 kb (see above) and at the same time
the former gap between the ExoN-deficient arterivirus group and
the large-genome nidoviruses that contain an ExoN signature
sequence has largely disappeared. Clearly, genome size unlikely
is the sole factor determining the requirement for an ExoN type
of proofreading function, as other factors (in particular RdRp
properties) may also prominently influence replication fidelity.
The rapid expansion of the nidovirus order has highlighted the
strict conservation of an array of five “core replicase” domains:
(i) the main (or “3C-like”) protease, (ii) the nidovirus RdRp-
associated nucleotidyl transferase (NiRAN), (iii) the RdRp, (iv)
a Zn-binding domain (ZBD), and (v) the superfamily 1 helicase
domain (HEL1), with which the ZBD is always associated
(Figure 1A; Lehmann et al., 2015; Saberi et al., 2018). When
present, the ExoN domain is found immediately downstream
of these nidovirus-wide conserved domains, often residing in
a bifunctional replicase cleavage product that also contains
an N7-guanine methyltransferase (N7-MTase) activity (Chen
et al., 2009; Bouvet et al., 2010), as in the case of CoV non-
structural protein (nsp) 14. The size of the ExoN domain
itself appears to be rather variable between different nidovirus
lineages, roughly between 150 and 250 amino acid (aa) residues,
depending on the presence or absence of two internal zinc
finger domains [(Nga et al., 2011) and unpublished observations]
(Figures 1B, 2A).
As mentioned above, for most of the novel metagenomics-
derived nidoviruses we only know genome sequences, and their
replication properties and enzymes have remained biologically
uncharacterized thus far. This is clearly different for CoVs, which
have a track record as an important group of (zoonotic) human
and veterinary pathogens. With some exceptions (Durzynska
et al., 2018), also the structure-function analysis of the nidoviral
ExoN enzyme has been based on CoV-derived variants of
the enzyme, on which we will focus our attention from
this point forward.
CORONAVIRAL RNAS AND
NON-STRUCTURAL PROTEINS
Like all nidoviruses, CoVs encode two very large replicase
polyproteins, pp1a and pp1ab (Figure 1A), of which the latter
derives from a ribosomal frameshift occurring just upstream
of the ORF1a termination codon. These primary translation
products of roughly 4,000–4,500 (pp1a) and 6,700–7,200 (pp1ab)
residues are processed by two or three internal proteases (residing
in nsp3 and nsp5) (Ziebuhr et al., 2000; Gorbalenya et al., 2006).
Most of the resulting 15 or 16 nsp cleavage products assemble into
a ribonucleoprotein complex that produces different types of viral
RNA transcripts. In the cytoplasm of the host cell, CoV infection
induces the formation of unusual double-membrane structures
that are thought to support viral RNA synthesis (Gosert et al.,
2002; Knoops et al., 2008). The synthesis of a nested set of
subgenomic (sg) mRNAs, one of the original nidovirus hallmarks
(L. nidus = nest), is a prominent CoV feature that drives the
expression of the genes located downstream of ORF1b, encoding
structural and accessory proteins (Figure 1A). An additional
complexity of CoV RNA synthesis is the fact that the sg mRNAs
are produced from a set of subgenome-length templates, which
are both 5′ and 3′ co-terminal with the full-length negative-
stranded template used for genome replication. The mechanistic
details of CoV RNA synthesis and its regulation have been
summarized elsewhere (Pasternak et al., 2006; Sawicki et al., 2007;
Sola et al., 2015).
Over the past 25 years, CoV replicase proteins have
been characterized using a combination of bioinformatics,
biochemistry, structural biology, and (reverse) genetics. By
now, in vitro biochemical assays have been described for most
(predicted) replicative enzyme functions. Increasingly supported
by the availability of structural information, several key CoV
enzymes were probed by site-directed mutagenesis, either using
in vitro assays or by launching engineered mutant CoV genomes
from cloned cDNA templates. The CoV replicase subunits nsp7
to nsp14 and nsp16 are most intimately associated with viral
RNA synthesis, either as enzymatic entity or as important
co-factor [for reviews, see (Gorbalenya et al., 2006; Decroly
et al., 2011b; Denison et al., 2011; Neuman et al., 2014;
Sevajol et al., 2014; Snijder et al., 2016)]. Key players are the
nsp12 and nsp13 subunits, which contain the RdRp and HEL
domains, respectively. Each of these proteins also carries a
unique N-terminal domain, NiRAN and ZBD, respectively, which
both are nidovirus-specific markers whose functional importance
remains to be studied in more detail (Lehmann et al., 2015;
Posthuma et al., 2017; Saberi et al., 2018; Kirchdoerfer and Ward,
2019). Several nsps (nsp10, nsp14, nsp16) have been assigned
functions in CoV mRNA capping and cap modification (Decroly
et al., 2008, 2011a; Chen et al., 2009; Bouvet et al., 2010; Snijder
et al., 2016), processes critical for both viral translation and innate
immune evasion (Zust et al., 2011). Several smaller subunits,
which will be discussed below, appear to act as crucial co-
factors of other nsps, and such nsp-nsp interactions are also
assumed to be highly relevant for the proofreading activity of
the nsp14-ExoN domain (Bouvet et al., 2014; Subissi et al.,
2014a; Ferron et al., 2018). Clearly, our understanding of CoV
replicase activities and the assembly of the viral RNA synthesizing
machinery continues to develop, which may ultimately help to
explain the evolutionary success of nidoviruses at large.
THE CORONAVIRUS RdRp IN THE
CONTEXT OF A MULTIMERIC ENZYME
COMPLEX
The C-terminal two-thirds of the CoV nsp12 subunit are
occupied by a canonical RdRp domain containing the commonly
encountered motifs A to F (Gorbalenya et al., 1989; Sevajol
et al., 2014; Posthuma et al., 2017; Kirchdoerfer and Ward, 2019).
Conserved aspartates in motif A and in motif C presumably are
responsible for the coordination of two essential metal ions in the
active site (te Velthuis et al., 2010; Ahn et al., 2012; Subissi et al.,
2014a). Most of our current knowledge of CoV RdRps is based on
studies with SARS-CoV nsp12, which will be summarized below.
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FIGURE 1 | (A) Outline of the CoV genome organization and expression strategy. Depicted are the SARS-CoV genome and its 14 open reading frames (ORFs), i.e.,
the replicase ORFs 1a and 1b, the four common CoV structural protein genes (S, E, M, and N) and the ORFs encoding “accessory proteins.” The bottom half of the
scheme summarizes the proteolytic processing and domain organization of the pp1a and pp1ab replicase polyproteins, the latter being produced by –1 ribosomal
frameshifting. The nsp3 (PLpro, green) and nsp5 (3CLpro, red) proteases and their cognate cleavage sites are indicated in matching colors. The resulting 16
cleavage products (non-structural proteins, nsps) are indicated, as are the conserved replicase domains that are relevant for this review. See main text for references
on nsp functions. Domain abbreviations and corresponding nsp numbers: PLpro, papain-like proteinase (nsp3); 3CLpro, 3C-like or main proteinase (nsp5); TM,
transmembrane domain (nsp3, nsp4, and nsp6); NiRAN, nidovirus RdRp-associated nucleotidyl transferase (nsp12); RdRp, RNA-dependent RNA polymerase
(nsp12); ZBD, zinc-binding domain (nsp13); HEL1, superfamily 1 helicase (nsp13); ExoN, 3′-to-5′exoribonuclease (nsp14); N7-MTase, N7-guanine methyl
transferase (nsp14); endoU, uridylate-specific endoribonuclease (nsp15); 2′-O-MTase, 2′-O-methyl transferase (nsp16); UTR, untranslated region. (B) Comparison of
the predicted domain organization in the replicase polyprotein of selected members of the nine families currently classified within the order Nidovirales (ICTV release
2018b). Adapted from Bukhari et al. (2018), with permission. Domains were predicted using HHPred-search (Soding, 2005; Zimmermann et al., 2018); for
abbreviations see the legend to panel A. Genbank accession numbers of sequences used: SARS-coronavirus (AY274119.3); Human coronavirus 229E
(AF304460.1); Bovine nidovirus 1 (KM589359.1); Sectovirus 1 (KX883637.1); White bream virus (DQ898157.1); Gill-associated virus (AF227196.1); Charybnivirus 1
(KX883628.1); Paguronivirus 1 (KX883627.1); Alphamesonivirus 1 (DQ458789.2); Turrinivirus 1 (KX883629.1); Equine arteritis virus (X53459.3); Aplysia abyssovirus
(NC_040711.1); Planidovirus 1 (MH933735).
A structural prediction of the nsp12-RdRp domain was
described as early as 2003 (Xu et al., 2003), but a crystal
structure of the protein is still lacking. However, very recently,
a cryo-EM-derived structure of SARS-CoV nps12, in a complex
with two copies of nsp8 and one copy of nsp7, was reported
(Kirchdoerfer and Ward, 2019). Like other + RNA viral
RdRps, the CoV RdRp displays a characteristic “cupped
right hand” organization, including thumb, palm and fingers
subdomains (Xu et al., 2003; Sexton et al., 2016; Posthuma et al.,
2017; Kirchdoerfer and Ward, 2019). A so-called “priming loop,”
a typical short β-strand that is considered to be a signature for
primer-dependent RNA synthesis, is lacking.
Technical challenges in obtaining stable and active
recombinant nsp12 have hampered the biochemical
characterization of CoV RdRp activity. Only poor enzymatic
activities were observed and initially both primer-dependent
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FIGURE 2 | (A) Amino acid sequence alignment of selected nidovirus ExoN domains, including those that have been characterized experimentally and are
discussed in this review, which mainly derive from members of the CoV family: SARS-CoV (NC_004718); MERS-CoV (NC_019843); HCoV-229E (NC_002645);
TGEV (P0C6Y5); MHV (NP_045298); IBV (NP_040829); Porcine delta CoV (PDCoV; NC_016990), WBV (NC_008516). SARS-CoV nsp14 secondary structure (PDB:
5NFY) is indicated on top, colored according to the following domain organization: nsp10-binding site (cyan), ExoN domain (orange), hinge region (purple),
N7-MTase domain (blue). Fully conserved residues are in red font and boxed, whereas partially conserved residues are displayed in red font (above 70%
conservation). Catalytic residues and residues involved in formation of zinc fingers are marked with asterisks and circles, respectively. (B) Web-logos highlighting the
three core motifs of the ExoN domain and the family of exonucleases to which it belongs.
RNA synthesis and de novo initiation were reported [reviewed in
(Snijder et al., 2016; Kirchdoerfer and Ward, 2019)]. However,
in the presence of the small nsp7 and nsp8 subunits, the
in vitro primer extension activity of nsp12 could be substantially
increased and de novo initiation was observed on a 339-nt
long template corresponding the 3′-terminal sequence of the
SARS-CoV genome (Subissi et al., 2014b). Recombinant SARS-
CoV nsp7 and nsp8 previously had been shown to multimerize
into a ring-shaped hexadecamer, which was proposed to act
as a processivity factor for the nsp12-RdRp while copying the
long CoV RNA genome (Zhai et al., 2005). Thus, CoV nsp12-
RdRp activity was postulated to depend on the formation of a
nsp7/nsp8/nsp12 tripartite complex, at least for some steps of
RNA synthesis. The exact stoichiometry of this complex remains
to be studied in more detail, particularly in the light of the
recently published cryo-EM structure of SARS-CoV nsp12, in
which the protein was complexed with a single nsp7/nsp8 dimer
plus an additional nsp8 monomer rather than an nsp7-nsp8
hexadecamer (Kirchdoerfer and Ward, 2019). It should be
noted that the in vitro RdRp activity of the latter complex
remains to be demonstrated. Furthermore, for feline coronavirus
(FCoV) nsp7 and nsp8, despite being structurally similar to
their SARS-CoV equivalents, a higher-order complex quite
different from the hexadecamer was described: a heterotrimer
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consisting of two copies of nsp7 and a single copy of nsp8
(Xiao et al., 2012).
Early in vitro assays using recombinant SARS-CoV nsp8
revealed an RNA polymerase activity typically generating
products of up to six nucleotides (Imbert et al., 2006). This
activity was implicated in the priming of CoV RNA synthesis,
particularly in light of the (predicted) absence of a priming loop
in the nsp12-RdRp domain (see above). Thus, nsp8 was proposed
to act as a primase that could synthesize small oligonucleotides
to be extended by the nsp12-RdRp. However, when studying the
activity of the nsp7/nsp8/nsp12 tripartite complex, no de novo
initiation by nsp8 was detected when the nsp12-RdRp domain
was inactivated by a motif C D760A substitution (Subissi et al.,
2014a). Most recently, an in vitro study employing nsp8 from
human coronavirus (HCoV) 229E could not establish nsp8-
associated primase or RdRp activities, but instead revealed a
3′-terminal adenylyl transferase activity that may serve to equip
viral transcripts with their 3′-poly(A) tail (Tvarogova et al., 2019).
Although, the importance of nsp8 as co-factor in RNA synthesis
is undisputed, its interplay with nsp12 clearly remains to be
investigated in more detail, in particular since the issue of nsp12
primer origin/usage seems to be wide open again.
TIMELINE OF DISCOVERY AND
CHARACTERIZATION OF
CORONAVIRUS EXON
The bioinformatics-driven discovery of the nidoviral ExoN
domain in 2003 was based on distant sequence similarities
with cellular homologs belonging to the DEDD superfamily
of exonucleases, such as the proofreading exonuclease domain
of Escherichia coli DNA polymerase I (Snijder et al., 2003).
Subsequently, the predicted 3′-to-5′ exoribonuclease activity was
confirmed using in vitro assays with recombinant SARS-CoV
nsp14 and synthetic RNA substrates (Minskaia et al., 2006). By
using reverse genetics, the same authors also demonstrated that
ExoN activity is critical for viability of the alphacoronavirus
HCoV-229E, as inactivation of the enzyme’s active site resulted
in a severe defect in overall viral RNA synthesis and a failure
to recover infectious viral progeny. Shortly thereafter, strikingly
different findings were obtained for the corresponding ExoN-
knockout mutants of two betacoronaviruses, MHV and SARS-
CoV (Eckerle et al., 2007, 2010), which are somewhat crippled,
but viable in cell culture. In strong support of the original
hypothesis that ExoN may act as a proofreading enzyme, ExoN
inactivation was found to confer a “mutator phenotype,” as was
evident from a 15- to 21-fold increase in mutation frequency –
relative to the wild-type (wt) control - during replication and
passaging in cell culture. The ability of ExoN to excise 3′-
terminal mismatched nucleotides from a double-stranded (ds)
RNA substrate was demonstrated in vitro using SARS-CoV nsp14
(Bouvet et al., 2010). This activity was strikingly enhanced by
the addition of nsp10, suggesting the two subunits operate as
a heterodimer in a mismatch repair mechanism that serves
to promote the fidelity of CoV RNA synthesis. Follow-up
studies from the Marseille laboratory also described the in vitro
association of SARS-CoV nsp14 with the nsp7/nsp8/nsp12
tripartite complex (Subissi et al., 2014a) and demonstrated that
ExoN can efficiently excise ribavirin 5′-monophosphate, possibly
explaining why this broad-spectrum antiviral drug is poorly
active against CoVs (Snijder et al., 2003; Ferron et al., 2018).
In the meantime, it had become clear that the ExoN-
containing nsp14 subunit of the CoV replicase, which is about
60 kDa in size, is a bifunctional protein. A genetic screening
approach in a yeast system revealed that the C-terminal domain
of nsp14 exhibits (N7-guanine)-methyltransferase (N7-MTase)
activity (Chen et al., 2009). Following the in vitro characterization
of its activity, this enzyme was implicated in the N7-methylation
of the (presumed) 5′-terminal cap structure of CoV mRNAs,
a modification that is critical for mRNA recognition by
the cellular translation machinery (Bouvet et al., 2010). The
bimodular ExoN/N7-MTase organization is conserved in most
nidovirus families, but the N7-MTase domain is lacking in,
e.g., toroviruses, bafiniviruses (Durzynska et al., 2018) and
several recently discovered nidoviruses (Figure 1B; Lauber
et al., 2013; Bukhari et al., 2018; Saberi et al., 2018). The
latter findings raise new questions about the mRNA capping
pathway(s) employed by these particular virus groups and
nidoviruses at large.
Crystal structures of SARS-CoV nsp14 in complex with its
nsp10 co-factor (PDB entries 5C8U and 5NFY) revealed several
unique structural and functional features (Ma et al., 2015; Ferron
et al., 2018). Below we will discuss nsp14 structure and function
in more detail, followed by a more extensive description of the
reverse genetics data obtained with ExoN-knockout mutants of
various CoVs and other functional considerations.
CORONAVIRUS nsp14 HARBORS
EXORIBONUCLEASE AND
N7-METHYLTRANSFERASE ACTIVITIES
The CoV ExoN domain was originally identified on the
basis of sequence similarities with distant cellular homologs
(Snijder et al., 2003) and classified into the superfamily of
DEDD exonucleases, which contains the proofreading domains
of many DNA polymerases as well as other eukaryotic and
prokaryotic exonucleases (Zuo and Deutscher, 2001). These
enzymes catalyze the excision of nucleoside monophosphates
from nucleic acids in the 3′-to-5′ direction using a mechanism
that depends on two divalent metal ions and a reactive water
molecule (Deutscher and Marlor, 1985; Beese and Steitz, 1991;
Steitz and Steitz, 1993). The name of the DEDD superfamily
derives from its four conserved active site residues that
are distributed over three canonical motifs (I, II, and III;
Figures 2A,B) in the primary structure (Bernad et al., 1989).
Originally, in SARS-CoV nsp14, residues D90/E92 (motif I),
D243 (motif II), and D273 (motif III) were identified as putative
active site residues (Snijder et al., 2003; Minskaia et al., 2006).
Subsequently, the SARS-CoV nsp14 crystal structure revealed
that ExoN in fact is a DEED enzyme as, instead of D243,
E191 was identified as the acidic active site residue in motif II
(Ma et al., 2015). Interestingly, when aligning ExoN sequences
Frontiers in Microbiology | www.frontiersin.org 6 August 2019 | Volume 10 | Article 1813
fmicb-10-01813 August 6, 2019 Time: 17:20 # 7
Ogando et al. The Nidovirus Exoribonuclease
FIGURE 3 | (A) Amino acid sequence alignment of the N7-MTase domains from the coronaviruses listed in Figure 2. See the Figure 2 legend for viruses and
accession numbers used. SARS-CoV nsp14 secondary structure (PDB: 5NFY) is indicated on top, and domain colors and sequence conservation are highlighted as
explained in the Figure 2 legend. Residues involved in the formation of the ZF3 zinc finger are marked with circles. (B) Web-logos highlighting the four
most-conserved motifs of the N7-MTase domain.
from different nidovirus taxa, D243 in SARS-CoV nsp14 is fully
conserved, whereas the equivalent of E191 alternates between
E and D (Figures 2A,B). The structural studies (Ma et al.,
2015; Ferron et al., 2018) also revealed the presence of a fifth
catalytic residue (H268 in motif III), identifying ExoN as a
member of the DEDDh/DEEDh subfamily (Barnes et al., 1995;
Zuo and Deutscher, 2001).
In contrast to nsp14’s ExoN activity, which was inferred
from bioinformatics analysis, the presence of an N7-MTase
in the C-terminal domain of nsp14 was not predicted. This
enzyme was discovered upon expression of TGEV and SARS-
CoV nsp14 in the yeast Saccharomyces cerevisiae, which
could rescue a mutant yeast strain lacking the native N7-
MTase (Chen et al., 2009). The N7-MTase activity was
further corroborated using biochemical assays with purified
recombinant SARS-CoV nsp14, which was found capable of
adding a methyl group to non-methylated cap analogs or
GTP substrates, in the presence of S-adenosyl methionine
(SAM) as methyl donor (Chen et al., 2009; Jin et al., 2013).
Alanine scanning mutagenesis and in vitro assays with nsp14
highlighted two clusters of residues that are key to the MTase
activity (Chen et al., 2009, 2013). The importance of the
first cluster, a canonical SAM-binding motif I (DxGxPxG/A;
Figures 3A,B) consisting of nsp14 residues 331–336, was
confirmed by 3H-labeled SAM cross-linking experiments (Chen
et al., 2009). The second cluster, encompassing residues
414 and 428, in the crystal structure forms a constricted
pocket that holds the GTP moiety of the cap structure
(GpppA) between two β-strands (β1 and β2) and helix 1
(Figure 4C). In this manner, nsp14 positions the N7 position
of the cap in close proximity of the methyl donor, thus
facilitating transfer by an in-line mechanism (Ma et al.,
2015). Comparative sequence analysis of N7-MTase domains
revealed that a number of residues crucial for substrate and
ligand binding are conserved among homologous enzymes
of different nidoviruses (Ma et al., 2015; Ferron et al., 2018;
Saberi et al., 2018).
Biochemical analysis confirmed that the two enzymatic
activities of nsp14 are functionally distinct (Chen et al.,
2009) and physically independent, as also deduced from the
structural studies summarized below (Ma et al., 2015; Ferron
et al., 2018). However, deletions within the ExoN domain,
N-terminal nsp14 truncations of between 78 and 90 amino
acids, and alanine substitutions in the N-terminal domain (R84A
and W86A) all drastically attenuated or completely abolished
the in vitro N7-MTase activity (Chen et al., 2009, 2013).
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FIGURE 4 | Overall structure of the SARS-CoV nsp14–nsp10 complex (PDB: 5NFY). (A) Cartoon representation of the crystal structure of the nsp14–nsp10
heterodimer, with domain colors used as follows: nsp10, green; nsp10-binding site of nsp14, cyan; nsp14 ExoN domain, orange; hinge region, purple; nsp14
N7-MTase domain, blue. The unresolved nsp14 residues 454–464 are represented by a dashed line. Zinc ions are shown as yellow spheres. (B) Cartoon
representation of SARS-CoV nsp14 (left) and its ExoN domain (right), highlighting the secondary structure elements referred to in the main text. (C) Close-ups of the
three zinc fingers (ZF) of nsp14 and the hinge region that connects the ExoN and N7-MTase domains. Arrows indicate the positional flexibility of the N7-MTase
domain, which is induced by the presence of the hinge region.
Although such changes may affect overall protein structure
and function, these results may also indicate that the two
enzymatic domains of nsp14 are structurally interconnected,
with N7-MTase activity depending on the integrity of the
N-terminal ExoN domain. On the other hand, the ExoN domain
is not directly involved in SAM binding by the N7-MTase
(Chen et al., 2009) nor does the N7-MTase activity depend on
the nsp10-nsp14 interaction that strongly enhances ExoN activity
(Bouvet et al., 2012).
STRUCTURAL BIOLOGY OF SARS-CoV
nsp14
The crystal structure of SARS-CoV nsp14 confirmed a bimodular
protein composed of ExoN and N7-MTase domains that are each
accompanied by an N-terminal structural domain (Figure 4A).
The overall protein architecture is as follows: (i) a flexible
N-terminal domain forming the nsp10 docking site, (ii) the
ExoN domain, (iii) a flexible hinge region consisting of a loop
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and three strands, and (iv) the C-terminal N7-MTase domain
(Ma et al., 2015; Ferron et al., 2018).
The CoV ExoN domain has an α/β fold reminiscent of other
members of the DEDD exonuclease superfamily (Derbyshire
et al., 1991). Its core is formed by a twisted central β-sheet
composed of five β-strands that are flanked by five α-helices
(Ma et al., 2015; Ferron et al., 2018). From this central domain,
an inserted β-hairpin structure containing β5 and β6 protrudes
to form with β1 a second anti-parallel β-sheet that binds to nsp10
(Figure 4B). Nsp14 interacts with nsp10 figuratively similar
to a “hand (nsp14) over fist (nsp10)” conformation (Ferron
et al., 2018). The fingers of the hand are formed by the flexible
N-terminal region of nsp14 (residues 1–50), β1 (residues 51–55),
and an antiparallel β-strand protruding from the ExoN domain
(residues 122–138), while the palm is composed of residues 55–
69 (top) and residues 195–202 (side) (Figure 4B). The interaction
with nsp10 induces conformational changes in the N-terminal
region of ExoN that modulate the distance between the catalytic
residues in the back of the nsp14 palm and, consequently, impact
ExoN activity (Ferron et al., 2018).
The CoV ExoN structure shares the conserved general
architecture of DEDD-type exonucleases, including other
proofreading ExoN domains like that of the Klenow fragment
of E. coli DNA polymerase I, the ε subunit of DNA polymerase
III (Ma et al., 2015), and another viral exonuclease (Yekwa
et al., 2019), currently being peer-reviewed. On the other hand,
distinguishing features are the N-terminal nsp10 interaction
domain, a β-hairpin structure containing β5 and β6 that also
interacts with nsp10, and two zinc finger (ZF) motifs. The first
zinc finger (ZF1) is placed between α4 and β10 and formed
by residues Cys207, Cys210, Cys226, and His229. The second
zinc finger (ZF2), comprising residues His257, Cys261, His264,
and Cys279, is located between α5 and α6 (see Figure 4C).
The H268 and D273 active site residues are embedded within
ZF2 (see Figure 2A), which is conserved among all nidoviruses
with the exception of PSCNV (Saberi et al., 2018). Site-directed
mutagenesis studies suggested that ZF1 contributes to the
structural stability of nsp14, since no soluble SARS-CoV nsp14
could be obtained upon ZF1 disruption. ZF2 is important for
catalysis, as replacement of important residues abolished the
enzymatic activity of recombinant ExoN (Ma et al., 2015).
The ExoN and N7-MTase domains of nsp14 are separated by
a hinge region that is conserved across CoVs. The hinge may
allow significant movement between the two enzymatic domains
by allowing lateral and rotational movements of the C-terminal
domain with respect to the N-terminal domain, which maybe
important to coordinate nsp14’s activities (Figure 4C). The nsp14
N7-MTase domain does not exhibit the canonical Rossmann fold
that is commonly found among RNA virus MTases or other RNA
cap 0 MTases (Byszewska et al., 2014; Chouhan et al., 2019) and
does not belong to any of the five classes of SAM-dependent
MTases (Schubert et al., 2003), adding another dimension to the
unique structural features of this bifunctional protein (Figure 5;
Ferron et al., 2018). In general, the Rossmann fold follows a
characteristic β-α-β architecture with seven parallel hydrogen-
bonded β-strands composing the core of the β-sheet structure,
with at least three α-helices on each side (Rao and Rossmann,
1973; Ferron et al., 2018). The nsp14 N7-MTase comprises a
total of 12 β-strands and five α-helices, with the central β-sheet
being composed of five β-helices instead of seven. Additionally,
the N7-MTase domain ends with an α-helix, α10, a modification
that stabilizes the local hydrophobic environment and is found
in SAM-dependent MTases (Martin and McMillan, 2002). A ZF
motif (ZF3) consisting of C452, C477, C484, and H487 is located
between strand β21 and helix α9 and is important for the proper
folding of this region (Figures 4C, 5). The three ZF motifs are a
specific structural signature of nsp14.
BIOCHEMICAL SUPPORT FOR
ExoN-DRIVEN ERROR CORRECTION
The first biochemical assays with purified SARS-CoV nsp14
demonstrated the capability to hydrolyze both double-stranded
(ds) and single-stranded (ss) RNA substrates in the 3′-to-5′
direction, with a preference for dsRNA substrates (Minskaia
et al., 2006). ExoN activity was not found to be RNA sequence-
specific, but DNA substrates were not degraded. Ribonuclease
activity depended on the presence of divalent metal ions, and
was strongly reduced or lost upon substitution of the predicted
catalytic residues in motifs I, II, or III with alanine (Minskaia
et al., 2006). Whereas basal ExoN activity does not require
the presence of co-factors (Minskaia et al., 2006; Chen et al.,
2007), Bouvet et al. (2012) demonstrated that SARS-CoV ExoN
activity is enhanced > 35-fold in the presence of nsp10, a small
ORF1a-encoded subunit of the CoV replicase that also serves
as a co-factor for nsp16’s 2′-O-methyltransferase (2′O-MTase)
activity (Bouvet et al., 2010). Mutagenesis of nsp10 surface
residues into alanine in many cases disrupted the interaction with
nsp14, leading to a significant reduction of ExoN activity and the
conclusion that nsp14 and nsp16 share a common interaction
surface on nsp10 (Bouvet et al., 2012, 2014). The nsp10/nsp14
complex preferentially degrades dsRNA substrates suggesting
that heterodimerization does not change ExoN’s substrate
specificity (Bouvet et al., 2012). Furthermore, RNA substrates
with a 3′-end duplex structure (like a stable hairpin) and fully
base-paired RNA substrates were also efficiently hydrolyzed by
the nsp10/nsp14 complex (Bouvet et al., 2012). Importantly,
in an assay intended to mimic RdRp incorporation errors, the
SARS-CoV nsp10/nsp14 complex was able to excise 3′-terminal
mismatched nucleotides from a dsRNA substrate (Bouvet et al.,
2012). A more elaborate analysis of ExoN substrate use and
specificity suggested that catalysis is determined by the presence
of mismatches rather than the nature of the misincorporated
nucleotide (Bouvet et al., 2012; Ferron et al., 2018). However,
when the stretch of 3′-terminal mismatched nucleotides was
increased beyond 2 nucleotides, a sharp decrease of excision
activity was observed (Bouvet et al., 2012). Comparable in vitro
mismatch excision activity was reported recently for the ExoN
domain of the bafinivirus white bream virus (WBV), using
dsRNA substrates containing up to three mismatches (Durzynska
et al., 2018). These assays were performed using WBV’s nsp14
equivalent alone, as no nsp10 homolog seems to be encoded by
bafiniviruses. Thus far, this study constitutes the only description
Frontiers in Microbiology | www.frontiersin.org 9 August 2019 | Volume 10 | Article 1813
fmicb-10-01813 August 6, 2019 Time: 17:20 # 10
Ogando et al. The Nidovirus Exoribonuclease
FIGURE 5 | (left) Comparison of MTase ribbon models of the canonical Rossmann fold (top) of the FtsJ MTase (PDB: 1EJ0) and the convergent fold of the
SARS-CoV nsp14 N7-MTase domain (bottom). Two orientations related by a 90◦ rotation along the vertical axis are shown. Secondary structures are colored to
highlight the topology: loop (gray), α-helix (white), and β-strands (green, orange, gold, green, light blue, red), extra α-helix and β-strand of nsp14 (salmon). (right)
Corresponding topology diagrams of Rossman fold MTases and the nsp14 N7-MTase domain. β-strands (triangles) and α-helices (circles) follow the same color code
as for the ribbon representation in panel A. The β− α− β structural motif, which defines the Rossmann fold, is boxed.
of in vitro ExoN activity for a nidovirus that does not belong
to the CoV family.
The above studies provided the first biochemical evidence
that ExoN, likely in concert with the tripartite RdRp complex
(nsp7/nsp8/nsp12 in CoVs), may function as a proofreading
enzyme that preferentially targets 3′-terminal single mismatches.
Indeed, SARS-CoV nsp14 and the nsp7/nsp8/nsp12 complex
were able to associate with each other, while retaining their RNA
synthesis, N7-MTase, and exoribonuclease activities (Subissi
et al., 2014b). Although, the structural basis of the interaction(s)
between nsp14 and the nsp12-RdRp domain remains to be
elucidated, in vitro studies revealed that both the ExoN and
N7-MTase domains of nsp14 are involved (Ferron et al.,
2018). Recent biochemical studies provided more insight into
the interplay between the SARS-CoV nsp7/nsp8/nsp12 RdRp
complex and the nsp10/14 heterodimer (Ferron et al., 2018).
Using a primer-template substrate containing an A:A mismatch
at the 3′ end of the primer, extension of the primer was barely
observed, suggesting that the SARS-CoV RdRp encounters a
kinetic block to extend a substrate with a 3′-terminal mismatch
(Ferron et al., 2018). Strikingly, addition of nsp10/nsp14 to
this assay appeared to relieve these constraints and full-length
polymerization products were observed, suggesting that ExoN
had removed the A:A mismatch before polymerization was
resumed. Sequencing of RNA products revealed that 90% had
the corrected sequence (Ferron et al., 2018). Similarly, ribavirin
5′-monophosphate (a guanosine analog) was efficiently excised
from RNA substrates in the presence of nsp14 or nsp10/nsp14
(Ferron et al., 2018).
Together with the mutator phenotype observed for ExoN-
knockout mutants of SARS-CoV and MHV (see below), the
above data strongly suggest that ExoN contributes to the fidelity
of CoV RNA synthesis. It is striking, that in vitro single-
nucleotide incorporation assays the SARS-CoV RdRp complex
(nsp7/nsp8/nsp12, without nsp14) displayed a lower fidelity
than the RdRp of dengue virus, a flavivirus with a three-fold
smaller genome (Ferron et al., 2018). Clearly, a direct in vitro
comparison of the properties of (distantly related) viral RdRps
is not straightforward. Moreover, our perception is “fragmented”
(at best. . .) when it comes to the biochemical evolution of
RdRp and ExoN features following the postulated acquisition
of the latter by an ancestral nidovirus (Snijder et al., 2003;
Nga et al., 2011). ExoN acquisition may indeed have facilitated
genome expansion, but - to an unknown extent - it may
also have relaxed the nucleotide selectivity of the RdRp, and
therefore the fidelity of RNA synthesis, which would be in
line with the biochemical observations outlined above (Ferron
et al., 2018). This would also leave space for the possibility
that nidoviruses may exist which combine the use of ExoN
with an intrinsic RdRp fidelity that is substantially higher
than that observed for present-day CoVs. In fact, also this
scenario may have contributed to expand nidoviral genomes
to the currently known upper limit (41.1 kb for PSCNV)
(Saberi et al., 2018) and (potentially) beyond. In this light,
it would be highly interesting to perform similar in vitro
assays to establish and compare the intrinsic RdRp fidelity of
diverse nidoviruses, including those with the longest genomes
and those naturally lacking an ExoN domain (Ferron et al.,
2018). Subsequently, nucleotide incorporation assays combining
RdRps and their cognate ExoN may provide important insights
into the biochemical synergy of the two enzymes, and may
ultimately allow us to correlate intrinsic RdRp fidelity and ExoN
activity across the broad spectrum of viruses included in the
nidovirus order.
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CHARACTERIZATION OF
CORONAVIRUS ExoN-KNOCKOUT
MUTANTS
The study from the Ziebuhr laboratory that demonstrated SARS-
CoV nsp14 in vitro exoribonuclease activity (Minskaia et al.,
2006) also described the first engineered ExoN-knockout CoV
mutants. However, for biosafety reasons, these experiments were
performed using the alphacoronavirus HCoV-229E rather than
the betacoronavirus SARS-CoV. The intracellular accumulation
of HCoV-229E RNA was found to be severely reduced (by
approximately 2 log) for several ExoN active site mutants in
motifs I, II, and III. Moreover, relative molar ratios of sg mRNAs
were altered and the production of alternative sg transcripts was
suspected, based on an analysis of the low amounts of viral
RNA produced in transfected cells. Most importantly, infectious
virus progeny could not be recovered from the medium of cells
transfected with full-length RNA carrying ExoN-inactivating
mutations, and consequently ExoN activity was concluded to be
critical for HCoV-229E replication (Minskaia et al., 2006).
If SARS-CoV rather than HCoV-229E had been the subject
of this initial reverse genetics study, the conclusions would
have been quite different. Subsequent work from the Denison
and Baric laboratories showed that the replication of equivalent
ExoN-knockout mutants of SARS-CoV and MHV was affected
but certainly not abolished (Eckerle et al., 2007, 2010). This was
the case when substituting conserved acidic residues of either
motif I (D90/E92 in SARS-CoV; mutant ExoN1) or motif III
(D273, mutant ExoN3) by alanine. For MHV, these mutations
reduced overall viral RNA synthesis (by 75–90% for both genomic
and sg RNA) and delayed replication (by several hours), whereas
also a specific change in sg mRNA synthesis was observed
(reduced mRNA2 production). In MHV, progeny titers of ExoN-
knockout mutants were reduced up to 1 log, with plaque sizes
of ExoN-knockout mutants also showing extreme heterogeneity
(Eckerle et al., 2007). For the corresponding SARS-CoV mutants,
progeny titers were about fourfold reduced without a clear overall
change in replication kinetics (Eckerle et al., 2007), although
intracellular RNA synthesis was not studied in detail. Upon
serial passaging in cultured cells, sequence analysis using both
conventional and next-generation techniques revealed that the
genomes of ExoN-knockout MHV and SARS-CoV mutants
accumulated up to 21-fold more mutations than their parental
controls, thus providing direct experimental evidence for a
connection between ExoN activity and CoV replication fidelity
(Eckerle et al., 2007, 2010).
To investigate this “mutator phenotype” in vivo, mutant
ExoN1 was engineered in a mouse-adapted (MA) SARS-
CoV backbone (Graham et al., 2012). During its in vitro
characterization, this mutant’s progeny titers were reduced by
less than 1 log. Quantitative RT-PCR data indicated that the
accumulation of wild-type and mutant genome initially was
roughly equivalent (6 h p.i.), but that the mutant genome
accumulated to about 10-fold lower levels later in infection (24 h
p.i.), possibly due to the rapid accumulation of unfavorable
mutations (Graham et al., 2012). Similar to results obtained
upon passaging in cell culture, the ExoN1-MA SARS-CoV
mutant exhibited an 11.5-fold increased mutation frequency. The
virulence of this mutant was attenuated, resulting in (strongly)
reduced disease and expedited virus clearance (Graham et al.,
2012). Long-term persistent infection of SCID mice allowed a
comparison of mutational loads after 30 days, revealing 9.6-fold
more mutations across the genome for the progeny of ExoN-
deficient MA SARS-CoV.
As expected, due to their reduced replication fidelity and/or
impaired overall replication capacity, MHV and SARS-CoV
ExoN mutants display increased sensitivity to mutagenic agents
like the nucleoside analog 5-fluorouracil (5-FU) (Smith et al.,
2013). Similarly, an MHV mutant in which the interaction of
nsp14 with its nsp10 co-factor was predicted to be disturbed
by two mutations (R80A/E82A in nsp10) was more sensitive
to 5-FU than wt virus (Smith et al., 2015). Although this
finding could be taken as further support for the hypothesis
that it is the nsp10/nsp14 complex that acts as a proofreading
enzyme, the situation likely is more complex. Specifically, a
single alanine substitution at one of the nsp10 positions targeted
for MHV proved to be lethal in SARS-CoV (mutant nsp10-
H80A) (Bouvet et al., 2014). Also other nsp10 mutations that
disturb the interaction with nsp14 were lethal, and thus had a
much stronger impact on SARS-CoV viability than the direct
inactivation of ExoN’s enzymatic activity (Bouvet et al., 2014).
Taking into account that the nsp10/nsp14 and nsp10/nsp16
interaction regions overlap (Ferron et al., 2018), it can be
hypothesized that some of the nsp10 mutations interfere with
the activities of both complexes. Clearly, this raises important
questions about the (multi)functionality of nsp10 and/or the
nsp10-nsp14 complex in CoV replication.
Interestingly, and in spite of its reduced replication fidelity,
reversion of the MHV-ExoN1 mutant was not reported thus
far, even when it was serially passaged in cell culture 250
times (Graepel et al., 2017). However, over this long period of
time, the passaged mutant virus exhibited an eightfold higher
mutation frequency and accumulated a variety of adaptive
non-synonymous mutations. These were spread across the
genome and partially compensated for the replication defect
and decreased mutagen sensitivity, possibly by improving RdRp
fidelity or increasing “mutational robustness” (Graepel et al.,
2017). These compensatory mutations mapped to the nsp12-
RdRp domain and to nsp14 itself, but also to subunits like nsp8,
nsp9, and the nsp13 helicase domain. Full reversion of the ExoN1
mutations (DE→AA) would require a total of four nucleotide
substitutions, but neither full nor partial reversion was observed,
suggesting a narrow evolutionary pathway to reversion. It was
proposed that replacement of only one of the active site residues
suffices to minimize ExoN activity, as observed for the 3′-to-5′
exonuclease of E. coli polymerase I (Derbyshire et al., 1991), and
that reversion at just one of the two motif I sites offers no selective
advantage compared to the double mutant (Graepel et al., 2017).
In view of the replication competence of MHV and SARS-
CoV ExoN-knockout mutants summarized above, it is striking
that equivalent mutants proved to be non-viable in at least three
other CoVs: HCoV-229E (Minskaia et al., 2006), transmissible
gastroenteritis virus (TGEV) (Becares et al., 2016), and –
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most recently – also MERS-CoV, according to an extensive
mutagenesis study from our own laboratory. Using a replicon
system for the alphacoronavirus TGEV, genome replication and
sg mRNA synthesis were found to be only modestly reduced
upon mutagenesis of ExoN active site residues (Becares et al.,
2016). Interestingly, a Cys-to-His change of the second Zn-
coordinating residue of ZF1 (residue C210), severely affected sg
mRNA synthesis while only mildly affecting genome replication.
Upon introduction into the full-length TGEV genome, mutations
equivalent to those in the SARS-CoV ExoN1 and ExoN3
mutants prevented the recovery of infectious progeny, with
quantitative RT-PCR assays indicating a ∼15-fold reduction
in the accumulation of genomic RNA. Additionally, a second
ZF1 mutation, His-to-Cys at the position of the fourth Zn-
coordinating residue (H229), did not strongly affect TGEV
RNA synthesis or progeny titers, but was reported to trigger a
weaker TGEV-induced antiviral response. This was attributed to
a reduced accumulation of viral dsRNA, an important pathogen-
associated molecular pattern (PAMP) that is recognized by
innate immune sensors, which triggered a decrease of IFN-β
mRNA synthesis and of IFN-induced immune factors in cell
culture (Becares et al., 2016). Unfortunately, no information is
available on the enzymatic activity or replication fidelity of the
two TGEV ExoN ZF1 mutants, which would be required to
better understand the interesting phenotype of these mutants
and their capability to modulate innate immune responses.
The assumption that the viable ZF1 mutant (H229C) possesses
increased ExoN activity, which could explain the reduced
levels of dsRNA in infected cells, seems premature. Alternative
explanations for this phenotype include changes in the efficiency
or kinetics of RNA synthesis. Moreover, the reported reduction of
viral double-stranded RNA accumulation by this mutant should
be interpreted with caution, as this conclusion was based solely
on the in situ immunodetection of dsRNA using a monoclonal
antibody with a poorly defined specificity for CoV dsRNA
replication intermediates. For example, it remains unknown how
changes in the protein composition or subcellular localization
of the RNA-synthesizing complex may affect the accessibility of
dsRNA epitopes during such immunolabeling experiments.
The results recently obtained with ExoN-knockout mutants
MERS-CoV are equally intriguing, particularly since MERS-
CoV is a betacoronavirus, like MHV and SARS-CoV. Using an
elaborate set of ExoN active site mutants, carrying conservative
or alanine substitutions, it was found that ExoN inactivation is
lethal in MERS-CoV and that no sign of viral RNA synthesis
can be discovered in cells transfected with these mutants full-
length RNA. Again, these observations suggest that the ExoN
domain and/or nsp14 (also) play a more direct and basic role
in CoV RNA synthesis than merely safeguarding the long-term
fidelity of replication.
THE REMARKABLE PHENOTYPIC
VARIATION AMONG ExoN-KNOCKOUT
MUTANTS
As summarized above, depending on the CoV studied, the impact
of ExoN inactivation on viral RNA synthesis ranges from a
complete block (MERS-CoV) to various degrees of impairment,
with residual RNA production supporting the generation of
infectious progeny only in the case of MHV and SARS-CoV.
For both these betacoronaviruses, in spite of their “mutator
phenotype,” the long-term consequences of ExoN inactivation
seem limited during propagation in cell culture. Viral RNA
synthesis might indeed be expected to tolerate, at least to a
certain extent, the inactivation of a proofreading activity that
was postulated to not be directly required for RdRp activity,
but to merely boost the overall quality of the replication
process. Clearly, when replicating in the absence of a functional
ExoN, deleterious mutations would first have to accumulate
before viral fitness would begin to decrease. This does not
appear to be the case for a third betacoronavirus, MERS-CoV,
and for two alphacoronaviruses, HCoV-229E and TGEV, for
which the immediate (full to strong) disruption of viral RNA
synthesis was observed when ExoN-knockout mutants were
launched by transfection of full-length RNA or DNA. In our
opinion, technical variations are unlikely to explain these viability
differences: with the exception of TGEV, ExoN knockout mutants
were commonly launched by electroporation of in vitro produced
full-length RNA into the cytosol of BHK-21 cells, thus providing
an equal environment for the first, critical rounds of replication
in a cell line that is known to be compromised in its innate
immune response (Lam et al., 2005; Habjan et al., 2008). During
our studies with the non-viable MERS-CoV ExoN mutants, we
attempted to amplify progeny virus released from transfected
BHK-21 cells in both immune-competent and -incompetent cells
(e.g., Huh7 and Vero cells, respectively) with an equally negative
outcome. Thus, in addition to proofreading, ExoN somehow
appears to play a more basic role in the functionality of the CoV
RNA-synthesizing machinery, by virtue of its exoribonuclease
activity, as a domain of the bifunctional nsp14 subunit, and/or
as an interaction partner for other nsps in the viral RNA-
synthesizing machinery.
Among the CoVs investigated thus far, MHV and SARS-
CoV (in our experience) do stand out as the two viruses
exhibiting the most robust RNA synthesis and overall replication
in cultured cells. Possibly, the replication activity of ExoN-
deficient mutants somehow needs to cross a certain “threshold”
to result in infectious progeny, and for ExoN-deficient mutants
this is only achieved with the CoVs that replicate most efficiently.
However, when considering the phenotypic differences of
knockout mutants, in terms of virus viability and sensitivity
to mutagenic agents in cell culture, it remains difficult to
reconcile the reported 1- to 2-log reduction of progeny titers
for ExoN-knockout MHV and SARS-CoV with the complete
loss of infectious progeny reported for the ExoN-knockout
mutants of various other CoVs. It is also relevant to consider
the fact that low levels of residual enzymatic activity of
ExoN active site mutants may go unnoticed in biochemical
assays, but could still support a certain level of replication
when launching the RNA of an ExoN-knockout CoV mutant.
Despite the conservation of ExoN among CoVs and most other
nidoviruses, the extent to which particular mutations affect
enzymatic activity can only be assessed when studying these
specific viral proteins in a biochemical assay (Becares et al., 2016;
Case et al., 2016, 2018).
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Interactions with the host’s innate immune system have been
suggested to co-determine the phenotype of ExoN-knockout
CoV mutants (Kindler and Thiel, 2014; Becares et al., 2016;
Case et al., 2018). It has been proposed that CoV nsp14, by
virtue of its ExoN activity, may counteract innate responses
by degrading dsRNA replication intermediates in a similar
manner as documented for the ExoN domain of the arenavirus
nucleoprotein (Hastie et al., 2011; Russier et al., 2014). As
CoVs employ a range of innate immune evasion mechanisms
(Kindler and Thiel, 2014), it is difficult to study the importance
of any single mechanism in a straightforward manner, as
other innate immune antagonists will continue to operate in
cells infected with mutants lacking one particular immune
evasion function.
Case et al. (2018) showed that MHV ExoN(−) virus
is sensitive to IFN-β, and that its replication is strongly
attenuated in innate immune-competent bone marrow-derived
macrophages (BMMs), an effect that was partially restored in
interferon-alpha/beta receptor knockout (IFNAR−/−) BMMs.
However, upon infection with the MHV-ExoN 1 mutant, neither
upregulation of interferon mRNA expression nor induction of
the OAS/RNAseL or PKR pathway was observed, in contrast to
what would be expected if nsp14 would indeed degrade a PAMP
like viral dsRNA. The MHV ExoN1 mutant yielded progeny with
a ∼10-fold reduced specific infectivity and decreased relative
fitness. This property was attributed to the lack of ExoN activity,
but the mechanisms underlying the reduced fitness and altered
IFN sensitivity remain to be investigated (Case et al., 2018).
As summarized in the previous paragraph, TGEV ExoN active
site mutants were non-viable (see also above), but an nsp14
mutant carrying a ZF1 mutation (H229C; close to the interaction
region with nsp10) was reported to accumulate less dsRNA in
infected cells and trigger a weaker antiviral response (Becares
et al., 2016). These results could be taken to suggest that ExoN
may modulate innate immune responses, but TGEV nsp14
remains to be characterized biochemically and for now one
can only speculate about the level of ExoN activity of this
particular mutant.
Several cellular interferon-stimulated gene products have been
implicated in the hypermutation of viral genomes, so it remains
to be established how directly the properties of ExoN mutants
are determined by a lack (Case et al., 2018) or surmised increase
of exoribonuclease activity (Becares et al., 2016). An additional
functional consideration is the fact that the bulk of CoV dsRNA
replication intermediates were found to be confined to peculiar
double-membrane vesicles, which are part of the CoV replication
organelle that drives viral RNA synthesis in infected cells (Knoops
et al., 2008; Neuman, 2013). This feature, which in itself has
been proposed to be an innate immune evasion strategy, would
potentially complicate access of nsp14 to viral dsRNA substrates.
Nsp14: AN ATTRACTIVE TARGET FOR
ANTIVIRAL DRUG DESIGN?
Currently, there are no FDA-approved antiviral drugs for the
treatment of CoVs, which is mainly due to limited interest from
the side of the pharmaceutical industry, despite the loss of human
lives during the short-lived SARS outbreak and the continuing
MERS epidemic. Moreover, antiviral hits identified so far often
suffered from poor selectivity indexes. Drug development efforts
were further restricted by the limitations of available animal
models and potency failure in clinical trials (Zumla et al.,
2016). Taking into account the combination of ExoN and N7-
MTase activities in a single protein, and its importance in viral
replication, CoV nsp14 is an attractive target for antiviral drugs.
Thus far, only two classes of compounds that (in)directly interfere
with its activities have been analyzed in more detail: nucleoside
analogs and methyltransferase inhibitors.
Nucleoside analogs can have different mechanisms of action.
They may interfere with RNA synthesis directly (for instance
by obligate chain termination) or may inhibit virus replication
indirectly, for example by inducing lethal mutagenesis or
perturbing intracellular nucleoside triphosphate pools. The ExoN
proofreading function might counteract these compounds mode
of action and, in order to circumvent this, a nucleoside would
need to be incorporated more efficiently than it will be excised by
ExoN, or should be resistant to ExoN-mediated removal (Crotty
et al., 2000; Smith et al., 2013; Warren et al., 2016; Agostini
et al., 2018). Recently, in spite of these potential complications,
GS-5734 (Remdesivir, a monophosphoramidate prodrug of an
adenosine analog) was shown to be a potent inhibitor of the
replication of human and zoonotic CoVs in vivo and in vitro
(Warren et al., 2016; Sheahan et al., 2017; Agostini et al., 2018).
Compared to the wt control, replication of the MHV ExoN1-
knockout mutant was inhibited more efficiently by GS-5734,
suggesting that the compound’s activity is limited by ExoN’s
capability to excise and remove it after its incorporation into
the RNA chain by the viral RdRp. The simultaneous targeting of
RdRp and ExoN functionality with a combination of a nucleoside
analog and a specific exoribonuclease inhibitor may also be worth
exploring. In the case of nucleoside analogs like ribavirin, such
an approach may even restore antiviral efficacy against CoVs
and other viruses equipped with a proofreading mechanism
(Ferron et al., 2018).
Regarding the inhibition of the nsp14 N7-MTase, only a
few compounds have been identified that inhibit its activity
in vitro: adenosylhomocysteine, aurintricarboxylic acid (ATA),
and sinefugin (Bouvet et al., 2010; Sun et al., 2014; Aouadi et al.,
2017). Further work is needed to optimize these hits in order
to study their activity in vivo, and investigate their specificity
for this viral enzyme. Taking into account the unique fold of
the N7-MTase enzyme compared to other MTases, this might
facilitate the drug development of specific compounds targeting
this domain (Ma et al., 2015; Ferron et al., 2018).
CONCLUSION AND FUTURE
DIRECTIONS
The order Nidovirales constitutes a + RNA virus lineage
displaying a unique combination of molecular biological
features, including a genome size that ranges from “somewhat
above average” (arteriviruses, 12–16 kb) to the largest RNA
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virus genomes currently known (PSCNV, 41 kb). Upon its
discovery, promoted by the relationship with other proofreading
exonucleases, the ExoN domain was postulated to have played
an important role in nidoviral evolution and genome expansion
(Snijder et al., 2003) by providing a proofreading activity
that enhances the replication fidelity. Indeed, now that the
nidovirus order has grown substantially over the past decade,
the conservation of ExoN across a wide range of distantly
related nidoviruses with genome sizes above 18 kb testifies to the
important role this enzyme must play. Consequently, this role
was incorporated in an advanced theoretical model of nidoviral
genome dynamics (Lauber et al., 2013; Saberi et al., 2018),
in which the ancestral expansion of ORF1b, which includes
the ExoN domain, facilitated the subsequent growth of other
parts of the genome. In parallel, experimental evidence has
accumulated, mainly derived from studies with the well-studied
betacoronaviruses SARS-CoV and MHV, leaving little doubt
about the involvement of ExoN in fidelity control during genome
replication (Minskaia et al., 2006; Eckerle et al., 2007, 2010;
Bouvet et al., 2012; Graham et al., 2012; Ferron et al., 2018).
While the increasing genome size upper limit and the
discovery of a proofreading mechanism constitute clear and
exciting paradigm shifts in RNA virology, important questions
regarding ExoN function and importance remain to be resolved.
Among these, the wide phenotypic variation among the ExoN-
knockout mutants of the different CoV species studied thus
far (see above) is a remarkable issue. In this case, it appears
to be particularly challenging to integrate the results from
biochemistry, structural biology, (reverse) genetics, and the
analysis of CoV-infected cells into a coherent model of ExoN
function. It might also be instructive to reassess the increased
mutation frequency and evolution of ExoN-knockout mutants
using more advanced deep-sequencing methods that have been
developed during recent years (Acevedo et al., 2014).
Although most of the ORF1b-encoded key replicative enzymes
of CoVs (nsp12, nsp13, and nsp14) and their co-factors (nsp7,
nsp8, and nsp10) now have been characterized in vitro, it is
still quite unclear how these findings can be extrapolated to
the viral enzyme complex in the infected cell (Ulferts et al.,
2011; Snijder et al., 2016). The impressive long-term passaging
experiment with the MHV ExoN1 mutant (Graepel et al.,
2017) nicely illustrates the complexity and plasticity of the
CoV replication machinery, documenting how a network of
compensatory mutations in a variety of other nsps can – in
the long run – help the virus to survive and circumvent an
ExoN activity defect. Unfortunately, such studies are technically
challenging or impossible for CoVs yielding non-viable ExoN-
knockout mutants. In this context, it is necessary to expand the
biochemical and structural characterization of CoV replicative
enzymes, including ExoN, to other CoV species than SARS-CoV.
Further elucidation of the structure-function interplay
between ExoN and other (viral and/or host) members of the
CoV replication machinery will be key to understanding their
role in viral RNA synthesis, immune evasion and pathogenesis.
Such information will contribute to the design of new antiviral
approaches, or the improvement of existing ones, including those
relying on inducing “lethal mutagenesis” (Ferron et al., 2018).
Likewise, it will allow a better assessment of the applicability
of ExoN inactivation as a broad strategy for designing live-
attenuated vaccines against CoVs or other nidoviruses (Graham
et al., 2012), which – in terms of vaccine production – clearly
depends on the viability of ExoN-knockout mutants. In this
context, it would be highly interesting to explore the partial
inactivation of ExoN in CoVs for which full inactivation was
proven to be lethal. Now that metagenomics studies have
informed us about the evolutionary success and remarkably
broad host range of nidoviruses, it is important, more than ever
before, to enhance our preparedness and design strategies to
counter nidoviruses that are likely to emerge in human or animal
host populations.
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